Anavex Life Sciences Corp (AVXL)

[kund]

Here is what happening in Anavex land

1) phase2b data is not robust, all started with lousy trial design based on tiny phase2a, no detail phase2b data ever coming.
2) Based on few signals in phase2b there will be full fledge phase3 may be with n >1000
3) Expecting excellence data is good, provided Misleading don't come up with post-hoc end points, otherwise kiss goodbye to this company like Cortexyme
4) Misleading expect stock to pop up on excellence data , again no fumble . Then dilute heavily for AD phase3 and pay huge bonus and options to management.
5) After launching phase3 AD, Misleading will be out as CEO, again all depend upon excellence data.